Our experiments further revealed that additional silencing of METTL3 cannot further decrease the phosphorylation level of mTORC1 and glycolysis activity in Rapamycin‐treated (mTOR‐suppressed) HCC cells. This evidence concerns the gene MTOR and hepatocellular carcinoma.